petunidin-3-glucoside has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, YL; Jin, B; Li, ZL; Liu, X; Lu, L; Luo, Q; Mi, J; Ran, LW; Yan, YM; Zeng, XX | 1 |
1 other study(ies) available for petunidin-3-glucoside and Prostatic Neoplasms
| Article | Year |
|---|---|
The main anthocyanin monomer of Lycium ruthenicum Murray induces apoptosis through the ROS/PTEN/PI3K/Akt/caspase 3 signaling pathway in prostate cancer DU-145 cells.
Topics: Anthocyanins; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Fruit; Glucosides; Humans; Lycium; Male; Membrane Potential, Mitochondrial; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Reactive Oxygen Species; Signal Transduction | 2021 |